Valuation Sandu Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. 06:02:31 2026-10-01 EDT			5-day change	1st Jan Change
36.53 ^INR	+0.91%		-1.27%	-2.40%

09-11	Sandu Pharmaceuticals Limited Approves Appointment of Neeti Madan Kapre as Non Executive Independent Director, Effective 11 July 2026	CI
09-11	Sandu Pharmaceuticals Limited Approves Re-Designation of Balram Viswanathan as Managing Director, Effective from 11 July 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	253.1	619.8	593.1	554.4	473.3	294.9
Change	-	144.92%	-4.32%	-6.51%	-14.64%	-37.7%
Enterprise Value (EV) ¹	136.7	578.1	570.1	543	451.5	230.5
Change	-	322.88%	-1.38%	-4.75%	-16.85%	-48.95%
P/E	20.7x	37.6x	32.4x	38x	30.6x	16.7x
PBR	0.76x	1.7x	1.29x	1.37x	1.13x	0.68x
PEG	-	1.8x	-2.3x	-6.01x	5.13x	1.2x
Capitalization / Revenue	0.43x	0.95x	0.91x	0.82x	0.7x	0.42x
EV / Revenue	0.23x	0.88x	0.87x	0.81x	0.67x	0.33x
EV / EBITDA	6.91x	21.5x	24.5x	25.5x	17.8x	8.34x
EV / EBIT	8.53x	24.7x	29x	31.7x	21.6x	9.92x
EV / FCF	2.36x	-540x	-50.5x	-60.4x	-254x	4.79x
FCF Yield	42.4%	-0.19%	-1.98%	-1.66%	-0.39%	20.9%
Dividend per Share ²	0.5	0.75	0.75	0.8	0.8	1
Rate of return	1.56%	1.07%	1.44%	1.39%	1.63%	3.28%
EPS ²	1.54	1.87	1.612	1.51	1.6	1.828
Distribution rate	32.5%	40.1%	46.5%	53%	50%	54.7%
Net sales ¹	587.6	655	653.5	672.8	671.9	699.3
EBITDA ¹	19.8	26.94	23.23	21.3	25.4	27.65
EBIT ¹	16.02	23.44	19.69	17.12	20.94	23.23
Net income ¹	10.92	15.89	15.2	14.61	15.52	17.66
Net Debt ¹	-116.4	-41.71	-22.96	-11.43	-21.76	-64.37
Reference price ²	31.95	70.35	52.20	57.39	48.99	30.52
Nbr of stocks (in thousands)	7,921	8,811	11,362	9,661	9,661	9,661
Announcement Date	9/6/21	9/7/22	9/6/23	9/5/24	9/6/25	8/19/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SANDU PHARMACEUTICALS LIMITED	-	-	-	-	3.67M
ELI LILLY AND COMPANY	32.45x	11.78x	23.93x	0.61%	1,019B
JOHNSON & JOHNSON	28.48x	6.32x	17.7x	2.09%	617B
ABBVIE INC.	33.26x	7.78x	16.08x	2.64%	464B
MERCK & CO., INC.	104.98x	5.87x	24.89x	2.36%	356B
ROCHE HOLDING AG	18.81x	4.58x	11.36x	2.9%	333B
NOVARTIS AG	19.83x	5.17x	12.78x	3.09%	267B
ASTRAZENECA PLC	20.02x	4.17x	11.86x	2.13%	244B
AMGEN INC.	25.46x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.78x	6.39x	24.97x	2.27%	179B
Average	26.61x	6.52x	17.27x	2.29%	369.72B
Weighted average by Cap.	31.80x	7.61x	18.61x	1.96%